TDACU
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Shell Companies · US
$11.43
−0.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.15x
- PEG TTM
- —
- Price / book
- 1.72x
- Price / sales
- —
- Price / cash flow
- 47.44x
Enterprise value
- Enterprise value
- $300.9M
- EV / sales
- —
- EV / EBITDA
- -318.52x
- EV / EBIT
- -318.52x
- Market cap
- $300.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026